Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- BriaCell Therapeutics Corp (NASDAQ:BCTX) has opened recruitment and enrollment of their collaborative clinical study with Incyte Corporation (NASDAQ:INCY).
- The Phase 1/2a combination study will evaluate BriaCell's lead candidate, Bria-IMT, with Incyte's retifanlimab & epacadostat to treat advanced breast cancer.
- BriaCell and Incyte had previously treated two patients under this Phase I/IIa combination study after the corporate collaboration commencement in April 2019.
- Bria-IMT in heavily pretreated advanced breast cancer patients achieved 12 months of average overall survival benefit. The top responder achieved 21.4 months survival plus 100% resolution of an eye-bulging orbital tumor.
- Price Action: BCTX shares are up 3.25% at $6.04 during the premarket session on the last check Wednesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!